EU Moves to Improve Conditions for Embattled Biotech Sector, Ananda’s Clinical Development Pushes On, & Celadon Remains on the Brink - Cannabis News World

EU Moves to Improve Conditions for Embattled Biotech Sector, Ananda’s Clinical Development Pushes On, & Celadon Remains on the Brink - Cannabis News World

In response to this growing exodus of promising biotech firms, the European Union has proposed a new Biotech Act, as part of ongoing efforts by the European Commission to strengthen the continent’s biotechnology and biomanufacturing sectors, which have struggled with fragmented rules and sluggish approval processes. The post EU Moves to Improve Conditions for Embattled Biotech Sector, Ananda’s Clinical Development Pushes On, & Celadon Remains on…

EU Moves to Improve Conditions for Embattled Biotech Sector, Ananda's Clinical Development Pushes On, & Celadon Remains on the Brink - Business of Cannabis

Welcome to Business of Cannabis’ new weekly strategic digest tracking the financial health, market moves, and corporate developments shaping the European cannabis sector. The frenetic pace of company updates across various cannabis-based sectors comes as the industry prepares to descend on Berlin and London for European Cannabis Week where the latest insights from the world’s leading voices will take centre stage across four separate events taki…